Navigation Links
Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
Date:5/15/2008

at DDW

PEGINTRON

Results from the EPIC3 Program: Platelet Counts Are Strong Predictors of Sustained Viral Response (SVR) in the Retreatment of Previous Interferon/Ribavirin Non-Responders (NR). Poynard, T. et al. Poster S1000, Abstract No. 442673, Sunday, May 18, 8:00 a.m. - 5:00 p.m., Sails Pavilion.

Clearance of HCV at 5 Year Follow-Up for Peginterferon Alfa-2b with or without Ribavirin Is Predicted by Sustained Virologic Response at 24 Weeks Post-Treatment. Lindsay, K. et al. Poster S1001, Abstract No. 443097, Sunday, May 18, 8:00 a.m. - 5:00 p.m., Sails Pavilion.

Sustained Virologic Response and Relapse Rates with Peginterferon Alfa-2b Plus Ribavirin in Clinical Trials Are Comparable to Those in Community-Based Studies. Manns, M. et al. Poster W1004, Abstract No. 441859, Wednesday, May 21, 8:00 a.m. - 5:00 p.m., Sails Pavilion.

Rapid Virologic Response to Peginterferon Alfa and Ribavirin Treatment of Chronic Hepatitis C Predicts Sustained Virologic Response and Relapse. Poordad, F. et al. Poster W1007, Abstract No. 439219, Wednesday, May 21, 8:00 a.m. - 5:00 p.m., Sails Pavilion.

Boceprevir

Role of Interferon Response During Re-Treatment of Null Responders with Boceprevir Combination Therapy: Results of Phase II Trial. Schiff, E. et al. Oral Presentation 162, Abstract No. 442360, Sunday, May 18, 4:30 p.m., Room 6DE.

Schering-Plough Supported CME Symposium

Defining the Course in the Management of HCV: A Case Based Approach Sunday, May 18, 6:30-9:30 p.m., San Diego Marriott Hotel and Marina, Hall 3-6. A world-renowned faculty will present and discuss recent data and how this information may impact clinical management decisions. Among the educational objectives of this program is to define the role of viral clearance as a predictor of HCV treatment response.

About PEGINTRON

In the United States, PEGINTRON is indicated for use alone or with ribavirin for the treatment of chronic hepatitis
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
2. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
3. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
4. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
5. Schering-Plough Reports Top-Line Results of the IDEAL Study
6. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
7. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
8. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
9. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
10. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
11. Sarasotas Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimers Disease Research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009).... 20 The National Association of D...d a new initiative in the war on methamphetamine. ...multi-state electronic tracking program that enfor... medicines containing pseudoephedrine in real-time...s based on a system that was developed and tested ...
(Date:11/20/2009)... 20 The Department of H... members of priority groups that did not have prev...inics are being held statewide on Nov. 20-22. Frid...on Saturday, Nov. 21, will be 8 a.m. to 2 p.m. On ....m. to 8 p.m. ,, Individuals in the recommende...
(Date:11/20/2009)... Reportlinker.com announces that a ...alogue. ,, Pipettes & Pipettors - A Global...er.com/p0164373/Pipettes--Pipettors---A-Global-Mar..._medium=pr&utm_campaign=prnewswire ,, Pip...t of any research laboratory. Large-scale applicat...
Breaking Medicine Technology:National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12ConnextionsHealth Introduces Turnkey Rapid Ramp Call Verification Solution 54979 1ConnextionsHealth Introduces Turnkey Rapid Ramp Call Verification Solution 54979 2ConnextionsHealth Introduces Turnkey Rapid Ramp Call Verification Solution 54979 3Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 1Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 2Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 3Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 4Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 5Video 3A Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month 54974 6Blood test can detect brain damage in amateur boxers 54969 1Blood test can detect brain damage in amateur boxers 54969 2
...tration show potential for,new option to improve c.../PRNewswire-FirstCall/ -- Millennium,Pharmaceutica...ive,data for VELCADE, the market-leading therapy f...ceived at least one prior therapy.,These data incl...,(SC) administration of VELCADE, a new option unde...
...rence, NORTH HOLLYWOOD, Calif., and CHICAGO, June ... Foundation (IMF)-supporting research,and providin...ents,families, researchers and physicians-today s... national clinical trial shows the,combination of ...of,survival by 41%. The follow-up study also showe...
Other Medicine Technology:New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 2New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 3New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 4New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 5New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 6New Data on Market-Leading Velcade (Bortezomib) for Injection,Further Strengthen Role in Previously Treated Multiple Myeloma 7Study Shows Velcade Plus Doxil Improves Survival in Previously,Treated Patients With Multiple Myeloma 2
(Date:11/20/2009)...DISON, N.J., Nov. 20 Rat...ay have peaked in late October, but the pandemic f...ness in all age groups, including the elderly, acc...orated (NYSE: DGX ), the world,s leading provide... ,, In its most recent Quest Diagnostics Healt...
(Date:11/20/2009)...ON-SALEM, N.C., Nov. 20 ...sion to redefine what it means to be "happy" durin...or with a specialty in family counseling and chair...iversity, Gladding says research shows that it is ...ss and even depression during the holidays. ,, ...
(Date:11/20/2009)... of exposure to formaldehyde used for embalming in...eased risk of death from myeloid leukemia, accordi...the Journal of the National Cancer Institute . ,...m lymphohematopoietic malignancies and brain cance...y workers, all of whom may have worked with formal...
(Date:11/20/2009)...,s as short as 34 weeks, potentially adding to pre...AY, Nov. 20 (HealthDay News) -- Recent reports sho... climb in the United States. Now, a new study sug...t what constitutes a full-term birth in the first ...yed in the study considered a baby born at 34 to 3...
(Date:11/20/2009)... Longtime OB/GYN warns against the new br...reventative Services Task Force. These guidelines ...of human lives. When is it wrong to be safe than s...entative Services Task Force recommendations, publ...al Medicine, has set off a firestorm in the medica...
Breaking Medicine News(10 mins):Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Why Holidays Don't Have To Be 'Happy' 2Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Many Women Miscalculate Time to Full-Term Birth 2Health News:Many Women Miscalculate Time to Full-Term Birth 3Health News:Many Women Miscalculate Time to Full-Term Birth 4Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 2Health News:New Breast Cancer Recommendation May Cost Lives While Saving Money 3
...apy for early outset glaucoma appears to slow the ...ediate treatment of the most common form of glauco...s.// This has very few significant signs. Doctors ...of the group was treated with medicine and laser t...
...to researchersthey studied on miceand found that ... cells and eliminate them. Glioma is the most aggr...ll-defined, with malignant// cells making their wa... Institute have found that neural stem cells can t...
...cant focussed technique of radiation therapy promi...ase. These days a full cure is likely for most of ...ecovery may be impaired by short and long-term com...t researchers at Stanford University have been dev...
...iant that is linked to an increase in the risk of ...h diabetes are most likely to suffer neuropathy. I...thy in the lower limbs - that is, //peripheral ner...d a gene variant which makes people more likely to...
...to a Norwegian study of 1656 subjects over an elev...mes in the workplace is linked to a significant in...subjects from the city of Bergen and its surroundi...f the original participants were revisited. The su...
...to this new study it shows that women are more sen... in the US investigated a group of 60 women and 30...ugh.// They had them inhale substances that cause ...substances used were capsaicin, the hot substance ...
Other Medicine News:
...rs a complete line of flowmeters, available in oxy... in a variety of calibrations to best suit your ap...fic to the gas in use, the Amvex Flowmeter is a us...U with I. For Power Take-Off add PT to the end of ...
...rs a complete line of flowmeters, available in oxy... in a variety of calibrations to best suit your ap...fic to the gas in use, the Amvex Flowmeter is a us...U with I. For Power Take-Off add PT to the end of ...
MRI Compatible Slim Line Flowmeter
0-3.5 LPM Oxygen Flowmeter - 1/8" NPT Female Inlet
Medicine Products: